Indian Pazopanib Exporters: Complete Supplier Ranking with Market Share — 109 Manufacturers (2026) — TransData Nexus

Q: Who is the largest pazopanib supplier from India?

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the largest pazopanib exporter from India with a 66.6% market share and export value of $5.6M.

Q: How many pazopanib suppliers are there in India?

There are 109 active pazopanib exporters in India, collectively shipping $8.3M worth of pazopanib across 498 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top pazopanib suppliers from India?

The top 5 pazopanib suppliers from India — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SP ACCURE LABS PRIVATE LIMITED, TEYRO LABS PRIVATE LIMITED, GNH INDIA PHARMACEUTICALS LIMITED, BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED — together control 77.0% of total pazopanib export value from India.

Suresh Sormare

Pazopanib

India Pharmaceutical Trade Intelligence

$8.3M109 Suppliers57 CountriesHS 30049049

ExportsIndia → UNITED STATES84.4%India → GEORGIA2.6%

ImportsUNITED KINGDOM → India$3.3M SWITZERLAND → India$596.6K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: SUN PHARMACEUTICAL

Pazopanib Suppliers from India (2026) — 109 Exporters, $8.3M Market | TransData Nexus | TransData Nexus

Who Exports Pazopanib from India — 109 Suppliers Behind a $8.3M Market

India's pazopanib export market is supplied by 109 active exporters who collectively shipped $8.3M across 498 shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with a 66.6% market share, followed by SP ACCURE LABS PRIVATE LIMITED and TEYRO LABS PRIVATE LIMITED. The top 5 suppliers together control 77.0% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Pazopanib Suppliers & Exporters — 109 manufacturers, $8.3M export market, top destinations and formulations — Pazopanib supplier data — 109 exporters · $8.3M market · 498 shipmentsTransData Nexus · Indian Customs Data

Top Pazopanib Exporters from India — Ranked by Export Value

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the leading pazopanib exporter from India, holding a 66.6% share of the $8.3M market across 498 shipments from 109 exporters. The top 5 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SP ACCURE LABS PRIVATE LIMITED, TEYRO LABS PRIVATE LIMITED, GNH INDIA PHARMACEUTICALS LIMITED, BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED — collectively control 77.0% of total export value, indicating a highly concentrated market. Individual shares are: SUN PHARMACEUTICAL INDUSTRIES LIMITED (66.6%), SP ACCURE LABS PRIVATE LIMITED (3.7%), TEYRO LABS PRIVATE LIMITED (3.4%), GNH INDIA PHARMACEUTICALS LIMITED (2.2%), BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED (1.1%).

Top Pazopanib Exporters from India

Ranked by export value · 109 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Pazopanib Exporters from India — Ranked by Export Value. 109 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Pazopanib exporters

Certification and compliance status for top Pazopanib suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Sun Pharmaceutical Industries Limited	Approved	Yes	Yes	Multiple	Sun Pharma holds FDA approvals, WHO-GMP, and EU GMP certifications.

TransData Nexus reviewed the regulatory standing of 1 leading Pazopanib exporters from India. 1 hold US FDA facility approvals, 1 maintain WHO-GMP certification, and 1 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Pazopanib sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the country's bulk drug production. The city hosts more than 2,000 pharmaceutical companies, including major players like Dr. Reddy's Laboratories and Aurobindo Pharma. The establishment of Hyderabad Pharma City, recognized as a National Investment Manufacturing Zone in December 2019, further solidifies its position as a pharmaceutical hub. This ecosystem provides a robust infrastructure for the production of active pharmaceutical ingredients (APIs) essential for drugs like Pazopanib.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations industry. Vadodara, in particular, is home to Alembic Pharmaceuticals, a company with a significant presence in the production of formulations. The region's pharmaceutical industry benefits from a skilled workforce and a supportive regulatory environment, making it a key player in the formulation and export of medications such as Pazopanib.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical products. Mumbai, being a major port city, facilitates the efficient export of pharmaceuticals to global markets. The region's well-established logistics and regulatory framework support the seamless export of drugs like Pazopanib, ensuring timely delivery to destinations such as the United States, which accounts for the majority of Pazopanib exports.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Pazopanib exporters from India

June 24, 2024

Merger & Acquisition

SUN PHARMACEUTICAL INDUSTRIES LIMITED — Sun Pharma Completes Taro Merger

Sun Pharma successfully completed the merger with Taro Pharmaceutical Industries Ltd., acquiring all outstanding ordinary shares of Taro, making it a wholly-owned subsidiary. - IMPACT: This consolidation may enhance Sun Pharma's production capabilities, potentially affecting Pazopanib export volumes.

Impact: This consolidation may enhance Sun Pharma's production capabilities, potentially affecting Pazopanib export volumes.

TransData Nexus Industry Research · Regulatory filings and press releases · Mar 2026

Common Questions — Pazopanib Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which pazopanib supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with 9 recorded shipments worth $5.6M. SP ACCURE LABS PRIVATE LIMITED (6 shipments) and TEYRO LABS PRIVATE LIMITED (6 shipments) are also established high-volume exporters.

Q How many pazopanib manufacturers are there in India?

India has 109 active pazopanib exporters with a combined export market of $8.3M across 498 shipments to 57 countries. The top 5 suppliers hold 77.0% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for pazopanib from India?

Average FOB unit price: $67.65 per unit, ranging from $0.01 to $836.03. Average shipment value: $16.8K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Pazopanib

Pazopanib

Who Exports Pazopanib from India — 109 Suppliers Behind a $8.3M Market

Top Pazopanib Exporters from India — Ranked by Export Value

Top Pazopanib Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

SUN PHARMACEUTICAL INDUSTRIES LIMITED — Sun Pharma Completes Taro Merger

Common Questions — Pazopanib Suppliers from India

Q Which pazopanib supplier from India is the most reliable for bulk orders?

Q How many pazopanib manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for pazopanib from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Analysis Methodology